MyFinsight
Home
Blog
About
Back
Balance Sheet
Monopar Therapeutics (MNPR)
Monopar Therapeutics (MNPR)
source: myfinsight.com
Investments
$81,541,216
(493.09%↑ Y/Y)
Cash and cash
equivalents
$52,757,766
(33.56%↑ Y/Y)
Other current assets
$464,727
(-6.55%↓ Y/Y)
Total current assets
$134,763,709
(150.73%↑ Y/Y)
Operating lease
right-of-use asset
$215,120
(82.04%↑ Y/Y)
Total assets
$134,978,829
(150.58%↑ Y/Y)
Total liabilities and
stockholders equity
$134,978,829
(150.58%↑ Y/Y)
Total stockholders
equity
$130,854,970
(150.67%↑ Y/Y)
Total liabilities
$4,123,859
(147.83%↑ Y/Y)
Retained earnings
(accumulated deficit)
-$98,715,880
(-22.07%↓ Y/Y)
Additional paid-in capital
$229,472,821
(72.55%↑ Y/Y)
Total current
liabilities
$4,016,031
(153.60%↑ Y/Y)
Operating lease liability
- non-current
$107,829
(34.17%↑ Y/Y)
Accumulated other
comprehensive income (loss)
$91,317
(17.71%↑ Y/Y)
Common stock, par value
of 0.001 per share,...
$6,712
(9.55%↑ Y/Y)
Accounts payable,
accrued expenses and...
$4,016,031
(153.60%↑ Y/Y)
Back